NOVARTIS

0:01:16

Novartis mission

0:00:34

Novartis, Sandoz recall 12 medications over packaging concerns

0:00:52

Novartis – Who We Are

0:02:10

Novartis Life

0:24:07

Novartis CEO Vas Narasimhan on The David Rubenstein Show

0:03:45

Novartis not joining the 'frenzy' of weight loss drugs, CEO says

0:00:54

Novartis as a focused innovative medicines company

0:01:58

Novartis Raises Outlook After Sandoz Generics Spinoff

0:02:59

25 Years of Novartis – Continuing our innovation journey

1:13:57

Novartis Campus Lecture - RNA Revolution: A Conversation with Nobel Prize winner Katalin Karikó

0:06:51

Novartis CEO discusses how AI will impact drug development

0:01:37

Corporate responsibility at Novartis

0:01:15

Novartis CEO says FDA's extended approval of breast cancer drug is a 'landmark' for the firm

0:04:43

Novartis CEO: Our leukemia drug Scemblix is a potential $3 billion plus medicine

0:04:19

Novartis CEO on Acquisitions, AI, Weight-Loss Drugs

0:11:50

Novartis ‘focusing on high-end, innovative medicines,’ CEO says

0:51:16

Pokert Novartis auf Kosten der Patienten? Wenn Krebstherapien unbezahlbar werden | Doku | SRF Dok

0:23:37

Reimagining Medicine with Data & Digital | Novartis CEO at #VivaTech19

0:00:31

We’re with you

0:04:17

Novartis transformation into a pure-play Innovative Medicines company

0:01:12

Research and Development: It’s our heartbeat.

0:25:17

Novartis CEO Vas Narasimhan: How to be a boss in an “unbossed” company

0:04:22

Novartis CEO on new cancer therapy programs

0:04:34

Next Generation Scientist 2024